Immediate Impact
51 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums
2024 Standout
Works of Thomas E. Beniak being referenced
Zonisamide discontinuation due to psychiatric and cognitive adverse events
2010
Discontinuation of levetiracetam because of behavioral side effects
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas E. Beniak | 251 | 77 | 83 | 176 | 9 | 306 | |
| Dorothée Leunen | 232 | 64 | 85 | 152 | 9 | 345 | |
| Martin T. Lutz | 264 | 126 | 136 | 149 | 7 | 354 | |
| C. D. Ferrie | 209 | 46 | 104 | 147 | 11 | 292 | |
| Blaise Bourgeois | 262 | 33 | 98 | 191 | 14 | 306 | |
| Mercedes Garcés | 264 | 39 | 130 | 215 | 15 | 318 | |
| A. Schellekens | 291 | 38 | 91 | 236 | 7 | 340 | |
| Steffi Koch‐Stoecker | 298 | 45 | 85 | 203 | 12 | 332 | |
| Nerija Vaičienė-Magistris | 277 | 34 | 160 | 197 | 9 | 340 | |
| Jens‐Peter Reese | 248 | 21 | 68 | 203 | 18 | 333 | |
| L. D'Argenzio | 155 | 34 | 48 | 130 | 15 | 261 |
All Works
Loading papers...